- US12576147utility2026Recombinant Proteins with CD40 Activating Properties0 cites
- US12427141utility2025BYL719 (alpelisib) for Use in the Treatment of Pik3ca-related Overgrowth Spectrum (PROS-CLOVES Syndrome)0 cites
- US12351634utility2025Use of Cilengitide for Ameliorating Cardiac Fibrosis Occurring in Response to Myocardial Infarction0 cites
- US12173053utility2024Composition for the Treatment of Antibody Deficiencies0 cites
- US12144859utility2024B Cell Depleting Agent for the Treatment of Atherosclerosis0 cites
- US11857532utility2024Treatment and Prediction of Therapeutic Responses in Patients Suffering from Friedreich Ataxia0 cites
- US11718661utility2023Composition for the Treatment of Antibody Deficiencies0 cites